Skip to content

Potsdam Dream Research Parkinson

Potsdam Dream Research Parkinson - PotsDReam

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00029222
Enrollment
100
Registered
2022-06-20
Start date
2022-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: Deep brain stimulation (DBS) or Levodopa-/Apomorphin-pump-implantation

Sponsors

Ernst von Bergmann Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All consentable patients > 18 years old with diagnosed Parkinson's disease, who either receive DBS or a Levodopa- / Apomorphin-pump and who are physically and psychologically able to document their dreams.

Exclusion criteria

Exclusion criteria: Excluded are all minors and non-consentable patients and those unable to document their dreams.

Design outcomes

Primary

MeasureTime frame
Dream content according to the Calvin S. Hall and Robert Van de Castle system

Secondary

MeasureTime frame
L-Dopa equivalent dose, disease burden using Hoehn and Yahr (H & Y) scale, Unified Parkinson's Disease Rating Scale-I, II, III, IV (UPDRS) during on and off, Life quality using Short-Form 36 (SF-36), Parkinson’s Disease Questionnaire (PDQ-39), Self-efficacy, psychological well being using the Ardouin Scale of Behavior in Parkinson's Disease (ASBPD), Impulse control disorders using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP-RS), Cognition using the Mattis Dementia Rating Scale (MDRS), Questions regarding Religiosity / Spirituality in addition to the Daily Spiritual Experience Scale (DSES).

Countries

Germany

Contacts

Public ContactHolger Joswig

Ernst von Bergmann Klinikum

holger.joswig@klinikumevb.de+4933124137902

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026